Skip to Content

Paul Sondel

From Human Oncology

Jump to: navigation, search


Sondel paul.png

Paul Sondel

PROFESSOR

CONTACT INFORMATION

    Phone: (608) 263-9069
    E-mail:

    Mailing Address:
    4159 Wi Institute Medical Research
    1111 Highland Ave
    Madison, WI 53705

Education

Research

Awards

Recent Publications

Amy K Erbe, Wei Wang, Patrick K Reville, Lakeesha Carmichael, KyungMann Kim, Eneida A Mendonca, Yiqiang Song, Jacquelyn A Hank, Wendy B London, Arlene Naranjo, Fangxin Hong, Michael D Hogarty, John M Maris, Julie R Park, M F Ozkaynak, Jeffrey S Miller, Andrew L Gilman, Brad Kahl, Alice L Yu, Paul M Sondel
HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy.
Front Immunol: 2017, 8();675
[PubMed:28659916]

Rajen Mody, Arlene Naranjo, Collin Van Ryn, Alice L Yu, Wendy B London, Barry L Shulkin, Marguerite T Parisi, Sabah-E-Noor Servaes, Mitchell B Diccianni, Paul M Sondel, Julia G Bender, John M Maris, Julie R Park, Rochelle Bagatell
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Lancet Oncol.: 2017, 18(7);946-957
[PubMed:28549783]

Wei Wang, Amy K Erbe, Kenneth B DeSantes, Paul M Sondel
Donor selection for ex vivo-expanded natural killer cells as adoptive cancer immunotherapy.
Future Oncol: 2017, 13(12);1043-1047
[PubMed:28492088]

Alexander L Rakhmilevich, Mildred Felder, Lauren Lever, Jacob Slowinski, Kayla Rasmussen, Anna Hoefges, Tyler J Van De Voort, Hans Loibner, Alan J Korman, Stephen D Gillies, Paul M Sondel
Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.
J. Immunol.: 2017, 198(4);1575-1584
[PubMed:28062694]

Amy K Erbe, Wei Wang, Jacob Goldberg, Mikayla Gallenberger, KyungMann Kim, Lakeesha Carmichael, Dustin Hess, Eneida A Mendonca, Yiqiang Song, Jacquelyn A Hank, Su-Chun Cheng, Sabina Signoretti, Michael Atkins, Alexander Carlson, James W Mier, David J Panka, David F McDermott, Paul M Sondel
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.
Clin. Cancer Res.: 2017, 23(9);2159-2168
[PubMed:27742794]